Hedge funds and other institutional investors own 82.30% of the company’s stock. We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
According to 9 analysts, the average rating for DLB stock is “Buy.” The 12-month stock price forecast is $91.8, which is an increase of 13.47% from the latest price. Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade.
Dolby Laboratories stock is up more than 30% since the beginning of this year, and at the current price around $92 per share, we believe that Dolby Laboratories stock has over 15% potential downside. Our belief stems from the fact that DLB stock has doubled from its low in March this… This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company’s P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
DLB:USNew YorkDolby Laboratories IncCOMPANY INFO
Dolby Laboratories updated its second quarter earnings guidance on Thursday, February, 2nd. The company provided earnings per share guidance of $0.90-$1.05 for the period, compared to the consensus EPS estimate of $0.93. The company issued revenue guidance of $340-$370 million, compared to the consensus revenue estimate of $332.11 million. Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 39.27% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend. The brokerage set a “buy” rating on the electronics maker’s stock.
An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. Join thousands of traders who make more informed decisions with our premium features.
- One analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock.
- Dolby Laboratories’ fourth-quarter performance is likely to have benefited from Dolby Atmos and Dolby Vision.
- MarketBeat has tracked 6 news articles for Dolby Laboratories this week, compared to 3 articles on an average week.
- As of February 28th, there was short interest totaling 1,030,000 shares, an increase of 17.9% from the February 13th total of 873,700 shares.
- The Barchart Technical Opinion widget shows you today’s overally Barchart Opinion with general information on how to interpret the short and longer term signals.
Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.
Further, it provides 3-D glasses and kits; and various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California. Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares.
Finally, Barrington Research downgraded Dolby Laboratories from an “outperform” rating to a “market perform” rating in a research note on Friday, November 18th. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $98.67. High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.
First Trust Advisors LP raised its stake in Dolby Laboratories by 320.2% in the first quarter. First Trust Advisors LP now owns 1,081,747 shares of the electronics maker’s stock valued at $84,614,000 after purchasing an additional 824,296 shares in the last quarter. Norges Bank acquired a new position in Dolby Laboratories in the fourth quarter valued at about $38,977,000. Finally, Wells Fargo & Company MN raised its evfx reviewgreat forex brokers eu stake in Dolby Laboratories by 58.4% in the second quarter. Wells Fargo & Company MN now owns 1,077,995 shares of the electronics maker’s stock valued at $77,142,000 after purchasing an additional 397,471 shares in the last quarter. DLB, -0.53% shares fell more than 8% in the extended session Thursday after the audio company reported fiscal fourth-quarter earnings and sales below expectations, and guided for lower…
Earnings Preview: Dolby Laboratories (DLB) Q1 Earnings Expected to Decline
Dolby Laboratories has only been the subject of 1 research reports in the past 90 days. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. For US and Canadian Stocks, the Overview page includes key statistics on the stock’s fundamentals, with a link to see more.
Real-time quotes, advanced visualizations, backtesting, and much more. Dolby’s fiscal second-quarter results gain from strength in PC and Consumer Electronics, along with improved results for Dolby Cinemas. Dolby Laboratories possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
This is a decrease of -67% compared to the previous 30 days. Dolby Laboratories has only been increasing its dividend for 2 years. 1.74% of the float of Dolby Laboratories has been sold short.
Insiders & Institutions
Recently Viewed Tickers
Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price. Several other equities analysts have also recently weighed in on DLB. TheStreet raised shares of Dolby Laboratories from a “c” rating to a “b” rating in a research note on Friday, February 3rd. Rosenblatt Securities lifted their price objective on shares of Dolby Laboratories from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Friday, February 3rd. Finally, Barrington Research cut shares of Dolby Laboratories from an “outperform” rating to a “market perform” rating in a research report on Friday, November 18th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock.
Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Shares of Dolby Laboratories Inc. fell more than 4% in the extended session Thursday after the company reported fourth-quarter profit below Wall Street expectations. In the past three months, Dolby Laboratories insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,966,626.00 in company stock. Dolby Laboratories has a short interest ratio (“days to cover”) of 2.7, which is generally considered an acceptable ratio of short interest to trading volume. According to analysts’ consensus price target of $98.67, Dolby Laboratories has a forecasted upside of 22.1% from its current price of $80.79.
The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. DLB has a forward dividend yield of 1.35%.SeeDLB’s full dividends and stock split historyon the Dividend tab. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.